Richard J. Rodgers - Apr 30, 2025 Form 4 Insider Report for Opus Genetics, Inc. (IRD)

Role: Director
Signature: /s/ Amy Rabourn, by Power of Attorney
Stock symbol: IRD
Transactions as of: Apr 30, 2025
Transactions value $: $0
Form type: 4
Date filed: 5/2/2025, 05:09 PM
Previous filing: Jan 17, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Rodgers Richard J	Director	C/O OPUS GENETICS, INC., 8 DAVIS DRIVE, SUITE 220, DURHAM	/s/ Amy Rabourn, by Power of Attorney	2025-05-02	0001313397

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRD	Common Stock	Award	$0	+79.5K	+33.24%	$0.00	319K	Apr 30, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IRD	Stock Option (Right to Buy)	Award	$0	+79.6K		$0.00	79.6K	Apr 30, 2025	Common Stock	79.6K	$0.95	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
F2	The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.